Herndon Capital Management’s Zimmer Biomet ZBH Stock Holding History

Herndon Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$18K	Hold	146	–	–	﹤0.01%	103
2017 Q1	$17K	Buy	146 +40	+38%	+$4.53K	﹤0.01%	104
2016 Q4	$11K	Sell	106 -18	-15%	-$1.93K	﹤0.01%	129
2016 Q3	$16K	Sell	124 -396	-76%	-$48.9K	﹤0.01%	152
2016 Q2	$61K	Buy	520 +17	+3%	+$1.92K	﹤0.01%	131
2016 Q1	$52K	Buy	503 +11	+2%	+$1.06K	﹤0.01%	153
2015 Q4	$49K	Buy	+492	New	+$48.1K	﹤0.01%	160
2015 Q2	–	Sell	-134	Closed	-$15K	–	211
2015 Q1	$15K	Buy	+134	New	+$15.3K	﹤0.01%	157

Other funds holding ZBH

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Herndon Capital Management's ZBH Position: Q2 2017 in Review

Herndon Capital Management held its Zimmer Biomet (ZBH) position steady in Q2 2017 at 146 shares worth $18K. The position accounts for ﹤0.01% of the portfolio, ranked #103.

Herndon Capital Management first reported a position in ZBH in Q1 2015 and has held it in 8 quarters since. The position peaked at $61K in Q2 2016. 819 funds tracked by Wall St. Rank hold ZBH as of Q2 2017.

Herndon Capital Management held 146 shares of Zimmer Biomet worth $18K as of Q2 2017.
Herndon Capital Management left its Zimmer Biomet share count unchanged in Q2 2017.
Zimmer Biomet made up ﹤0.01% of Herndon Capital Management's portfolio in Q2 2017, its #103 holding.
Herndon Capital Management first reported a position in Zimmer Biomet in Q1 2015 and has held it in 8 quarters since.
Herndon Capital Management's Zimmer Biomet position peaked at $61K in Q2 2016.
819 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2017.

Based on Herndon Capital Management's 13F filing for Q2 2017, filed 4 Aug 2017.